ClinicalTrials.gg
CompletedNCT07885527Updated Oct 23, 2026

The Effects of Finger Painting During Nebulization Therapy on Fear and Anxiety Levels in Children

An interventional study of the finger-painting in CHİLD, sponsored by Firat University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 3 Years to 6 Years. Per ClinicalTrials.gov, last updated 2026-10-23.

Sponsored by Firat University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 1 year 2 months after the study started (first participant enrolled Aug 2025, registered Oct 2026).
Updated Oct 21, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
106
Allocation
Not applicable
Ages
3 Years to 6 Years
Sex
All
01

Study summary

Aim: This study was conducted to evaluate the effects of finger-painting intervention administered during nebulization therapy on the fear and anxiety levels of children.

Methods: This randomized controlled trial was conducted in the pediatric ward of a city hospital between August 2025 and February 2026. The study was completed with 106 children aged 3-6 years (study group = 53, control group = 53). The data were collected by using Demographic Information Form, Children's Fear Scale, and Children's Anxiety Scale-State Anxiety. The study group received finger-painting intervention during nebulization therapy, while the control group received only routine care.

Read the detailed description

The nurse assessments of the children in the study and control groups were conducted by the same nurse evaluator for all children throughout the study. Prior to the data collection process, the primary researcher provided the nurse evaluator with standardized training on the purpose of the study, the data collection process, and the administration of the measurement instruments.

The primary researcher is a master's student in Pediatric Nursing and has been working as a nurse in pediatric clinics for approximately three years. She has also received training in therapeutic play and holds a certificate in this field.

Before nebulization treatment, the children's levels of fear and anxiety were evaluated by the child, the parent, the evaluating nurse, and the primary researcher using the CFS and CAS-SA. In addition, parents completed the Parent Information Form. After the completion of the nebulization treatment, the children's levels of fear and anxiety were reevaluated by the same evaluators. Throughout the study, the primary researcher did not participate in the delivery of clinical care; she was responsible only for data collection and the implementation of the intervention.

The nurse assessments of the children in the study and control groups were conducted by the same nurse evaluator for all children throughout the study. Prior to the data collection process, the primary researcher provided the nurse evaluator with standardized training on the purpose of the study, the data collection process, and the administration of the measurement instruments.

The primary researcher is a master's student in Pediatric Nursing and has been working as a nurse in pediatric clinics for approximately three years. She has also received training in therapeutic play and holds a certificate in this field.

Before nebulization treatment, the children's levels of fear and anxiety were evaluated by the child, the parent, the evaluating nurse, and the primary researcher using the CFS and CAS-SA. In addition, parents completed the Parent Information Form. After the completion of the nebulization treatment, the children's levels of fear and anxiety were reevaluated by the same evaluators. Throughout the study, the primary researcher did not participate in the delivery of clinical care; she was responsible only for data collection and the implementation of the intervention.

The nurse assessments of the children in the study and control groups were conducted by the same nurse evaluator for all children throughout the study. Prior to the data collection process, the primary researcher provided the nurse evaluator with standardized training on the purpose of the study, the data collection process, and the administration of the measurement instruments.

The primary researcher is a master's student in Pediatric Nursing and has been working as a nurse in pediatric clinics for approximately three years. She has also received training in therapeutic play and holds a certificate in this field.

Before nebulization treatment, the children's levels of fear and anxiety were evaluated by the child, the parent, the evaluating nurse, and the primary researcher using the CFS and CAS-SA. In addition, parents completed the Parent Information Form. After the completion of the nebulization treatment, the children's levels of fear and anxiety were reevaluated by the same evaluators. Throughout the study, the primary researcher did not participate in the delivery of clinical care; she was responsible only for data collection and the implementation of the intervention.

Finger-Painting Intervention Administered to the Study Group Finger painting is an art-based therapeutic play activity used in pediatric care to distract children and encourage their active participation (Coyne, 2006; Koller \& Goldman, 2012; Li \& Lopez, 2008). In the present study, the finger-painting intervention was administered to the children in the study group during nebulization therapy.

Immediately before the nebulization therapy began, the procedure was explained to the children. The children were given blank paper and single-use, non-toxic, water-based finger paints in six primary colors, suitable for pediatric use. The children were allowed to choose the colors they wanted, mix colors or use them separately, and carry out the painting process according to their own preferences. No guidance was provided regarding the number of fingers used, the painting technique, or pattern creation during the painting process.

The finger-painting activity was initiated simultaneously with nebulization therapy, and the children were allowed to paint freely in their beds. The activity lasted approximately 5-10 minutes and concluded upon completion of the nebulization therapy. After the activity, the children's hands were washed with their parents' assistance in accordance with standard clinical practices. Children performing the finger-painting activity during nebulization therapy and the finger-painting materials used in the study (Picture 1).

Interventions to the Control Group No distraction methods or additional interventions were used for the children in the control group during nebulization therapy. The children received nebulization therapy solely as part of routine clinical care.

02

Conditions studied

  • CHİLD

Browse trials for

Keywords

  • Nebulization therapy
  • Finger-painting activity
  • Fear, Anxiety
  • Child
03

In context

Anxiety Disorders

5,063 studies on the registry are indexed under Anxiety Disorders; 1,408 are open to participants now.

This study's enrollment of 106 is above the median of 80 across 4,339 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Firat University is the lead sponsor of 117 studies on the registry; 46 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 6 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • For children:
  • Being between 3 and 6 years of age.
  • Being accompanied by a parent.
  • Being able to communicate in Turkish.
  • Having no allergy to chemical dyes, according to parental reports.
  • Having no mental or physical disabilities.
  • Having no history of chronic nebulizer use.

For parents:

  • Being able to communicate in Turkish.
  • Being literate.
  • Having no mental or physical disabilities.

Exclusion criteria

Exclusion Criteria:

  • For children:
  • Failing to complete the finger-painting intervention.
  • Having previously participated in a finger-painting intervention.
  • Having motor or functional impairments affecting the hands or fingers.

For parents:

- Having a mental health issue.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
106 participants (actual)

Study arms

  • Experimental
    Finger painting administered during nebulization therapy reduces children's fear and a

    Finger painting is an art-based therapeutic play activity in which children use their fingers and non-toxic paints to create images freely on paper. In pediatric care, this activity can serve as a distraction technique during medical procedures, supporting children's engagement and helping them cope with procedure-related fear and anxiety

    Other: the finger-painting

Interventions

  • Otherthe finger-painting

    Before nebulization therapy, the children were provided with finger paints and shown how to use them. They were then asked to engage in finger painting during the nebulization therapy.

06

What researchers measure

Primary outcomes

  1. assessing fear during nebulization therapy

    Children's Fear Scale: The scale was developed by McMurtry et al. to find out the anxiety levels of children between 4 and 10 years of age (McCarthy et al., 2010). There are five face pictures in the scale. Anxiety level is scored between "0 and 4". 0 indicates "no anxiety", while a scared face is scored 4 and indicates "too much anxiety". After the nebulization therapy ended, a researcher and parents filled Children's Fear Scale separately and independently to find out fear experienced by the child during the procedure.

    Time frame: 3-5 minutes.

Secondary outcomes

  1. assessing anxiety during nebulization therapy

    Children's Anxiety Scale-State Anxiety was developed by Ersig et al. (2013); the Turkish validity and reliability study was conducted by Gerçeker et al. (2018) (Gerceker Özalp et al., 2018; Ersig et al, 2013). The scale is used to evaluate the levels of state anxiety in children aged 4-10. The scale, which is in the form of a thermometer, is rated on a scale where 0 means "calm, not tense or anxious" and 10 means "very tense or anxious." After the nebulization therapy ended, a researcher and parents filled Children's Anxiety Scale separately and independently to find out fear experienced by the child during the procedure.

    Time frame: 3-5 minutes.

07

Study locations

1 site
  • Fırat University
    Elâzığ, 231000, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2025 to primary completion in Feb 2026, 6 months.

Of 2,720 non-industry interventional studies with no phase under Anxiety Disorders, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's 6 months is below that.

Counting every sponsor, half of 2,789 studies reached it within 12 months; a quarter within 5 and three quarters within 30.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 14, 2026
First posted
Oct 21, 2026
StartActual
Aug 3, 2025
Primary completionActual
Feb 3, 2026
CompletionActual
Feb 15, 2026
Last update
Oct 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 21, 2026
Show all 2 updates
  1. Oct 23, 2026
    Minor edits only
    + 2 other changes: identifiers and verification date
  2. Oct 21, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07885527
Lead sponsor
Firat University
Responsible party
DİDEM COŞKUN ŞİMŞEK (Principal Investigator, Firat University) — Principal investigator
First posted
Oct 21, 2026
Start date
Aug 3, 2025
Primary completion
Feb 3, 2026
Completion
Feb 15, 2026
Last update
Oct 23, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion